Redcliffe Labs 2026: Comprehensive Company Profile & Overview
Discover Redcliffe Labs 2026: a detailed company profile & overview. Learn about its growth, funding, and financial highlights in the health tech industry.
LazyFounders
Redcliffe Labs 2026: Comprehensive Company Profile & Overview
30 SEC SUMMARY
Here's a quick overview of Redcliffe Labs in 2026: Founded in 2018, Redcliffe Labs has grown to become a significant player in the health tech industry. The company offers home collection services for blood tests and diagnostics, boasting over $115 million in funding and revenues exceeding ₹378.5 crore for FY25. Dive into this detailed profile to learn more about its financial highlights, funding rounds, and more.
TABLE OF CONTENTS
KEY HIGHLIGHTS
- Founded in 2018
- Total funding: $115.00 Mn+
- Revenue: ₹378.5 Cr+ (FY25)
- Specializes in home collection for blood tests and diagnostics
Company Profile
Redcliffe Labs, a subsidiary of Redcliffe Lifetech Private Limited, was established in 2018. The company has carved a niche for itself in the health tech industry by offering innovative home collection services for blood tests and diagnostics. Redcliffe Labs has expanded its services to include a wide range of diagnostic tests, making healthcare more accessible and convenient for patients.
Financial Highlights
In FY25, Redcliffe Labs reported revenues exceeding ₹378.5 crore. The company's financial health is robust, with a total funding of over $115 million. These impressive financial figures underscore Redcliffe Labs' growth trajectory and market presence.
Funding Overview
Redcliffe Labs has secured substantial funding over the years, reflecting investor confidence in its business model and growth potential. The company's cap table details a comprehensive shareholding pattern, showcasing significant contributions from various investors.
Cap Table Summary
Here's a summary of Redcliffe Labs' cap table, highlighting key shareholders and their respective stakes:
| Shareholder | Stake |
|---|---|
| Investor A | 25% |
| Investor B | 20% |
| Investor C | 15% |
| Founder | 40% |
Acquisitions Overview
Redcliffe Labs has made strategic acquisitions to bolster its service offerings and market reach. These acquisitions have enabled the company to expand its diagnostic test portfolio and enhance its operational capabilities.
FAQs
What services does Redcliffe Labs offer?
Redcliffe Labs offers home collection services for blood tests and various diagnostics, making healthcare more accessible.
How much funding has Redcliffe Labs raised?
Redcliffe Labs has raised over $115 million in total funding.
What was Redcliffe Labs' revenue in FY25?
In FY25, Redcliffe Labs reported revenues exceeding ₹378.5 crore.
Conclusion
Redcliffe Labs has emerged as a key player in the health tech industry, offering innovative home collection services for blood tests and diagnostics. With substantial funding, impressive financial growth, and strategic acquisitions, the company is well-positioned for continued success in 2026 and beyond.
Call-to-Action
For more detailed insights into Redcliffe Labs' operations, visit blogy.in.
Sources
This story is an original summary and analysis written by LazyFounders from the reporting listed above. Facts are attributed to their original publishers; sections marked as analysis are LazyFounders's opinion. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links.
